<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04677257</url>
  </required_header>
  <id_info>
    <org_study_id>CoPhyTeA Trial</org_study_id>
    <nct_id>NCT04677257</nct_id>
  </id_info>
  <brief_title>Coronary Physiology Testing in Acute Coronary Syndromes</brief_title>
  <acronym>CoPhyTea</acronym>
  <official_title>Coronary Physiology Testing in Acute Coronary Syndromes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS San Raffaele</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an interventional, prospective, multicenter study (5 IRCCS hospitals belonging to the&#xD;
      Italian Cardiology Network) in patients with STEMI treated with successful primary PCI to&#xD;
      assess the ability of coronary physiology parameters measured soon after recanalization to&#xD;
      predict myocardial tissue characterization assessed with cardiac magnetic resonance (CMR)&#xD;
      within a week of the acute event. Furthermore, patients will be followed up for a period of&#xD;
      12 months to assess the incidence of major adverse cardiovascular events (death, death from&#xD;
      cardiovascular causes, re-infarction, new coronary revascularization interventions,&#xD;
      development of heart failure) based on their stratification according to coronary physiology&#xD;
      parameters.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the present study the investigators will enroll consecutive patients with STEMI acute&#xD;
      myocardial infarction treated with successful primary PCI, to assess the ability of coronary&#xD;
      physiology parameters, i.e. coronary flow reserve (CFR) and index of microvascular resistance&#xD;
      (IMR) measured after recanalization to predict myocardial tissue characterization (MVO, MSI,&#xD;
      IS, T2-rt, T1-rt and ECV) assessed with contrast CMR within a week of the acute event.&#xD;
      Furthermore, the relationship between left ventricular end-diastolic pressure and of coronary&#xD;
      physiology parameters will be evaluated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2, 2020</start_date>
  <completion_date type="Anticipated">November 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>interventional, prospective, multicentre study</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Defining the predictive value of the classification of patients based on coronary physiology</measure>
    <time_frame>5 ± 2 days of the acute event.</time_frame>
    <description>Establish the predictive value of the classification of patients based on coronary physiology measured in acute after primary PCI in patients with STEMI, on the incidence of microvascular obstruction (MVO) measured with CMR with contrast medium within 5 ± 2 days of the acute event.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>ST Elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>STEMI acute myocardial infarction treated with effective primary PCI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>STEMI patients treated with effective primary PCI to assess the ability of coronary physiology parameters (CFR and IMR) measured soon after recanalization to predict myocardial tissue characterization assessed with cardiac magnetic resonance (CMR) within a week of the acute event.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PCI, invasive coronary physiology and CMR</intervention_name>
    <description>Patients with acute STEMI will undergo invasive assessment of coronary physiology (IMR and CFR) following successful primary PCI and CMR within a week of the acute event</description>
    <arm_group_label>STEMI acute myocardial infarction treated with effective primary PCI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with STEMI (defined according to ESC Guidelines 2017), with symptom onset&#xD;
             within 12 hours (Class I), or between 12 and 48 hours (Class IIa), (1) successfully&#xD;
             treated with primary PCI. (1)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with previous myocardial infarction in the territory of the infarct-related&#xD;
             artery;&#xD;
&#xD;
          2. Patients with previous coronary artery bypass grafting;&#xD;
&#xD;
          3. Patients with cardiogenic shock at presentation;&#xD;
&#xD;
          4. Patients with need for mechanical support of the circulation;&#xD;
&#xD;
          5. Patients with known severe aortic stenosis / insufficiency;&#xD;
&#xD;
          6. Patients with known cardiomyopathy;&#xD;
&#xD;
          7. Patients with malignant neoplasm or systemic pathology with a &quot;quoad vitam&quot; prognosis&#xD;
             of less than 1 year;&#xD;
&#xD;
          8. Patients affected by known active infectious diseases;&#xD;
&#xD;
          9. Women who are pregnant or breastfeeding;&#xD;
&#xD;
         10. Patients who are unable to express valid informed consent upon enrollment;&#xD;
&#xD;
         11. Patients with hypersensitivity to the active ingredients used for the study of&#xD;
             coronary physiology (nitrates and adenosine);&#xD;
&#xD;
         12. Patients with specific contraindications to cardiac magnetic resonance imaging,&#xD;
             including:&#xD;
&#xD;
               -  Patients with allergies and / or with other specific contraindications to the use&#xD;
                  of paramagnetic contrast media (gadolinium), including chronic renal failure with&#xD;
                  glomerular filtrate (eGFR) &lt;30 mL / min;&#xD;
&#xD;
               -  Patients with non-resonance-compatible devices or who have undergone previous&#xD;
                  surgical interventions with placement of non-resonance-compatible vascular clips;&#xD;
&#xD;
               -  Claustrophobic patients.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paolo G Camici, MD, FACC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale San Raffaele</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paolo G Camici, MD, FACC</last_name>
    <phone>+39-022643-6202</phone>
    <email>camici.paolo@hsr.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Virna Vittozzi</last_name>
    <phone>+39-022643-6206</phone>
    <email>vittozzi.virna@hsr.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IRCCS AOU San Martino</name>
      <address>
        <city>Genova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Matteo Sarocchi, MD</last_name>
      <email>matteosarocchi@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Italo Porto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS Centro Cardiologico Monzino</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giovanni Monizzi, MD</last_name>
      <email>giovannimonizzi@hotmail.it</email>
    </contact>
    <investigator>
      <last_name>Antonio Bartorelli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS Ospedale San Raffaele</name>
      <address>
        <city>Milan</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paolo G Camici, MD</last_name>
      <phone>+3902-2643-6202</phone>
      <email>camici.paolo@hsr.it</email>
    </contact>
    <contact_backup>
      <last_name>Virna Vittozzi</last_name>
      <phone>+3902-2643-6206</phone>
      <email>vittozzi.virna@hsr.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>IRCCS Policlinico Gemelli</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rocco Montone, MD</last_name>
      <email>rocco.montone@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Filippo Crea, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS Multimedica</name>
      <address>
        <city>Sesto San Giovanni</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Flavio Airoldi, MD</last_name>
      <email>flavio.airoldi@multimedica.it</email>
    </contact>
    <investigator>
      <last_name>Gian Franco Gensini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 15, 2020</study_first_submitted>
  <study_first_submitted_qc>December 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2020</study_first_posted>
  <last_update_submitted>January 5, 2021</last_update_submitted>
  <last_update_submitted_qc>January 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS San Raffaele</investigator_affiliation>
    <investigator_full_name>Prof. Paolo G Camici MD FACC</investigator_full_name>
    <investigator_title>Prof Paolo G. Camici MD, FACC</investigator_title>
  </responsible_party>
  <keyword>coronary microcirculation</keyword>
  <keyword>coronary physiology</keyword>
  <keyword>CMR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

